# QNASL
> **NDA202813** · New Drug Application · Sponsor: TEVA BRANDED PHARM · Approved 2012-03-23
## Drug
- **FDA Application Number:** NDA202813
- **Application type:** New Drug Application
- **Brand name:** QNASL
- **Generic name:** BECLOMETHASONE DIPROPIONATE
- **Active ingredients:** BECLOMETHASONE DIPROPIONATE
- **Dosage form:** AEROSOL, METERED
- **Route:** NASAL
- **Marketing status:** Prescription
- **Sponsor:** TEVA BRANDED PHARM
- **Manufacturer:** Teva Respiratory, LLC
- **First approval:** 2012-03-23
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202813)
---
*AI Analytics · CC0 1.0*